ADGRE2
protein-codingadhesion G protein-coupled receptor E2, the group of Adhesion G protein-coupled receptors, subfamily E|CD molecules
Gene summary
This gene encodes a member of the class B seven-span transmembrane (TM7) subfamily of G-protein coupled receptors. These proteins are characterized by an extended extracellular region with a variable number of N-terminal epidermal growth factor-like domains coupled to a TM7 domain via a mucin-like spacer domain. The encoded protein is expressed mainly in myeloid cells where it promotes cell-cell adhesion through interaction with chondroitin sulfate chains. This gene is situated in a cluster of related genes on chromosome 19. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2012]
- EMR2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~46.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0007447
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007447
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007447
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADGRE2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013447.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 114 | 5 | 128 | ||
| missense | 1 | 291 | 40 | 25 | 357 | |
| nonsense | 1 | 16 | 4 | 4 | 25 | |
| start loss | 2 | 2 | ||||
| frameshift | 8 | 3 | 6 | 17 | ||
| splice donor/acceptor (+/-2bp) | 12 | 1 | 13 | |||
| Total | 0 | 2 | 338 | 161 | 41 | 542 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_038475.2 | 20 | MANE Select | |
| Ensembl | ENSP00000319883.3 | 20 | MANE Select | |
| RefSeq | NP_001257981.1 | 19 | Standard | |
| RefSeq | NP_690880.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- GPCRs, Other
- GPCRs, Class B Secretin-like
- Signaling by GPCR
- Signal Transduction
- Class B/2 (Secretin family receptors)
Biological Process
- inflammatory response
- cell adhesion
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
Molecular Function
- G protein-coupled receptor activity
- calcium ion binding
- chondroitin sulfate binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- integral component of membrane
- leading edge membrane
- ruffle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000315576
- Coding exons
- 20
- Length
- 46149
- Individuals with no LoFs
- 124800
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 947
- Defined
- 125748
- p
- 0.00378
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.654 | 430 | 470 | 0.915 | 0.0000273 | 5328 |
| Missense (PolyPhen) | 109 | 136.43 | 0.79893 | 1742 | ||
| Synonymous | 0.405 | 191 | 198 | 0.963 | 0.0000127 | 1616 |
| Loss of Function | 0.176 | 43 | 44.3 | 0.972 | 0.00000199 | 495 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0010 | 0.0010 | notable |
| Latino/Admixed American | 0.0018 | 0.0018 | notable |
| Ashkenazi Jewish | 0.00060 | 0.00060 | rare |
| East Asian | 0.0091 | 0.0091 | notable |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.0022 | 0.0022 | notable |
| South Asian | 0.014 | 0.014 | notable |
| Other | 0.0026 | 0.0024 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cell surface receptor that binds to the chondroitin sulfate moiety of glycosaminoglycan chains and promotes cell attachment. Promotes granulocyte chemotaxis, degranulation and adhesion. In macrophages, promotes the release of inflammatory cytokines, including IL8 and TNF. Signals probably through G- proteins. Is a regulator of mast cell degranulation (PubMed:26841242). {ECO:0000269|PubMed:12829604, ECO:0000269|PubMed:17928360, ECO:0000269|PubMed:22310662, ECO:0000269|PubMed:22575658, ECO:0000269|PubMed:26841242}.;
- Disease
- DISEASE: Vibratory urticaria (VBU) [MIM:125630]: An autosomal dominant disorder characterized by localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of mast cells and increased histamine levels in serum. {ECO:0000269|PubMed:26841242}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- RVIS EVS
- 2.36
- RVIS percentile EVS
- 98.44
Essentials
- Essential (gene trap)
- N